News & Publications


Learn more about Prous Institute and our progress in drug discovery, technology, industry partnerships, collaborations and scientific articles.

Prous Institute for Biomedical Research at Predictive Toxicology Summit 2014 (London, Feb 25-26, 2014)

2014 Jan 27 |

Prous Institute for Biomedical Research, a sponsor of the ANNUAL PREDICTIVE TOXICOLOGY SUMMIT to be held in London, Feb. 25-26, 2014, will introduce Prous Institute Symmetry®, the world’s first integrated in silico solution for drug discovery and safety screening.  The platform integrates models for a wide range of efficacy, toxicology and human adverse events endpoints, including models co-developed with the U.S. FDA.  Attendees will have the opportunity to learn how Symmetry is used to increase efficiencies in drug discovery and reduce safety-related drug attrition.   

For further information or to schedule a meeting during the conference, please contact